Calumet, Inc - Common Stock (CLMT)

Calumet Inc (CLMT) reports Q2 2025 loss of $1.70 per share, missing estimates despite revenue beat. Shares drop amid investor concerns over profitability.

Calumet shares rise after analyst highlights MaxSAF-driven EBITDA growth and debt reduction potential.

As we await the opening of the US market on Wednesday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.

Shares of Calumet and Gevo are on the move in extended trading Wednesday after the companies received conditional commitments from the U.S. Department of Energy (DOE).

CLMT stock results show that Calumet Specialty Prods beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

These hydrogen stock picks are boasting improving financials that even Wall Street can't deny. Check them out now!

Oil prices surge on anticipation of increased demand and ongoing supply constraints. Goldman Sachs projects continued demand growth until 2034.

CLMT stock results show that Calumet Specialty Prods beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

CLMT reports Q1 fiscal 2024 sales decline of 3%, beating consensus. Net loss per unit $(0.51) down from $0.23 YoY. Gross profit down 18.7% YoY.

Calumet reported Q4 sales decline of 2.3%, beating consensus. Gross profit down 38.3%. Plans to convert to C-Corp by 2024. Montana Renewables returned to normal operations in December.

Companies Reporting Before The Bell • Fomento Economico (NYSE:FMX) is likely to report quarterly earnings at $1.61 per share on revenue of $11.66 billion.

U.S. stocks traded higher, with the Dow Jones gaining around 100 points on Wednesday. Shares of HP Inc. (NYSE: HPQ) gained during Wednesday’s session following quarterly results.